z-logo
open-access-imgOpen Access
Timing of tofacitinib therapy is critical to improving outcomes in severe-critical COVID-19 infection: A retrospective study from a tertiary care hospital
Author(s) -
Ramya Kodali,
Soumya Umesh,
Sumithra Selvam,
Deepak Kamath,
Vineeta Shobha
Publication year - 2022
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000030975
Subject(s) - medicine , tofacitinib , odds ratio , retrospective cohort study , confidence interval , severity of illness , logistic regression , rheumatoid arthritis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here